Role of Etiology in Hepatocellular Carcinoma Patients Treated with Lenvatinib: A Counterfactual Event-Based Mediation Analysis

SIMPLE SUMMARY: Hepatocellular carcinoma is the fifth most common cancer worldwide. For patients with advanced hepatocellular carcinoma, therapeutic options are limited. Lenvatinib has proven to be an effective option for treating advanced diseases. For patients treated with lenvatinib, our study sh...

Descripción completa

Detalles Bibliográficos
Autores principales: Sacco, Rodolfo, Ramai, Daryl, Tortora, Raffaella, di Costanzo, Giovan Giuseppe, Burlone, Michela Emma, Pirisi, Mario, Federico, Piera, Daniele, Bruno, Silletta, Marianna, Gallo, Paolo, Cocuzza, Caterina, Russello, Maurizio, Cabibbo, Giuseppe, Rancatore, Gabriele, Cesario, Silvia, Masi, Gianluca, Marzi, Luca, Mega, Andrea, Granito, Alessandro, Pieri, Giulia, Giannini, Edoardo G., Paolillo, Rosa, Gadaleta-Caldarola, Gennaro, Dadduzio, Vincenzo, Giordano, Guido, Giacomelli, Luca, Papa, Simonetta, Renzulli, Matteo, Maida, Marcello, Ghidini, Michele, Borzio, Mauro, Facciorusso, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856921/
https://www.ncbi.nlm.nih.gov/pubmed/36672330
http://dx.doi.org/10.3390/cancers15020381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856921/
https://www.ncbi.nlm.nih.gov/pubmed/36672330
http://dx.doi.org/10.3390/cancers15020381

Ejemplares similares